Carl Walsh
VietnampatientMaleb. 19689.0Global Dominance: 0.00%Carl Walsh, a 59-year-old from Birmingham, has been participating in a clinical trial for a new cancer treatment after traditional therapies failed to manage his tongue cancer. Since beginning the trial in July, he has experienced significant improvements in his condition, including reduced swelling and pain, allowing him to regain some normalcy in his daily life.
Country presence
Recent news mentions
Carl Walsh, diagnosed with tongue cancer, participated in the amivantamab clinical trial and has shown significant recovery.
Thuốc tiêm mới có thể xóa sổ khối u ung thư giai đoạn cuốiVietnam· 2026-06-01
Carl Walsh was diagnosed with tongue cancer in May 2024 and joined the clinical trial in July 2025.
Index - Tech-Tudomány - Orvosi áttörés: egy új rákellenes injekció 15 végstádiumú betegnél teljesen eltüntette a daganatot
Hungary· 2026-05-31Carl Walsh, diagnosed with tongue cancer, was one of the first patients to benefit from the treatment.
Tratament împotriva cancerului cu rezultate fără precedent: injecția care poate elimina complet tumorile
Romania· 2026-05-31Carl Walsh, diagnosed with tongue cancer, shared his positive experience with the OrigAMI-4 trial treatment.
Cancer jab can eradicate entire tumours in patients, trial shows – The Irish Times
Ireland· 2026-05-30Carl Walsh, diagnosed with tongue cancer, expressed his satisfaction with the progress of his treatment in the OrigAMI-4 trial.
Cancer jab can eradicate entire tumours in patients, trial shows | Cancer research
United Kingdom· 2026-05-30Carl Walsh, a 59-year-old resident of Birmingham, shares how the treatment has improved his quality of life after being diagnosed with tongue cancer.
‘Injeção inteligente’ mostra promessa no tratamento de câncer avançado de cabeça e pescoço
Brazil· 2025-10-21
Carl Walsh, a patient with tongue cancer, shared his positive experience with the trial treatment amivantamab.
Smart jab can shrink head and neck cancer tumours within six weeks, trial finds | Cancer researchUnited Kingdom· 2025-10-19